RATIONALE: Prevalence of alpha-gal allergy due to meat allergy is unknown. Tick borne diseases have been reported to be on the rise in Florida. Despite presence of the Amblyomma americanum tick in the region, there is only one case report of alpha-gal allergy in Florida. We provide the clinical profile of a cohort of patients with alpha-gal allergy seen at our tertiary center. METHODS: We performed a retrospective chart review of adult patients with both, meat specific IgE, and detectable alpha-gal IgE evaluated from May 2016 to August 2018. Age, sex, total IgE, alpha-gal IgE as well as available specific IgE against meats or skin test results were collected. Presenting symptoms and presence of atopic disorders were noted. RESULTS: Twelve patients between ages 25-72 years of age were found to be sensitized to alpha-gal. Average alpha-gal IgE was 20 kU/L. Total IgE ranged from 15-478 kU/L. Most common presenting symptom was hives (n57). Other symptoms included: anaphylaxis, angioedema and GI symptoms. Sensitization to beef and pork was present in 75% of the patients. Sensitization to lamb was less common. While allergic rhinitis was present in 58% of patients, none reported a history of eosinophilic esophagitis or cetuximab treatment. CONCLUSIONS: Even though meat allergy has been thought to be uncommon, our findings highlight the increased incidence for this condition. Our report stresses the importance of considering alpha-gal sensitization especially when hives is the presenting symptom. We provide the first clinical description of a cohort of patients with alpha-gal sensitization associated with meat allergy in Florida. Family Allergy & Asthma, Louisville, KY. RATIONALE: Peanut allergy (PA) has significant impact on quality of life (QoL) of patients and their families. Comorbidity and poly-allergy disease burden in these patients has not been adequately described. METHODS : PatientSource  TM (PS   TM   ) proprietary, longitudinal patient claims database was utilized. Data from patients ages 4-17 years with PA between January 2011-December 2017 were identified using International Classification of Diseases (ICD)-9 and -10 codes. Severe reactions (SRs) were defined using codes for ''Sampson criteria,'' including anaphylaxis due to peanut, or symptoms of anaphylaxis (hypotension, cyanosis, acute respiratory failure), or hypersensitivity symptoms involving > _2 organ systems (cutaneous, respiratory, conjunctival, gastrointestinal), or PA-related ER visits. Comorbidities and poly-food-allergy (poly-FA) were identified using ICD-9/-10 codes. Adjustment for <100% claims capture rate and ;30% PA diagnosis under-coding was applied. RESULTS: Approximately 1.25 million cases of PA were identified; 720,490 patients identified in calendar year 2011 were followed over 6 years. Most common comorbidities were eczema (63%) and asthma (61%); 42% had eczema and asthma. Rate of SRs was highest in patients with multiple comorbidities (51% PA only; 49% PA+asthma; 58% PA+eczema; 61% PA+eczema+asthma). Multiple FAs were observed in 35% of patients; SR incidence increased with poly-FAs (PA only 47%; PA+1FA 65%; PA+2FA 67%; PA+3FA 77%; PA+4FA: 92%). , and Kenji Matsumoto, MD PhD 3 ; 1 Department of Pediatrics, Juntendo University, Faculty of Medicine, Tokyo, Japan, 2 Department of Pediatrics, Kochi University, Kochi, Japan, 3 Department of Allergy and Clinical Immunology, National Research Institute for Child Health and Development, Tokyo, Japan. RATIONALE: Atopic dermatitis (AD) is a chronic recurrent inflammatory skin disorder caused by epidermal barrier dysfunctions and immune dysregulations induced by genetic and environmental factors. During infancy, the manifestations of AD vary according to age-specific stages; AD initially develops in the absence of allergic sensitization. We hypothesized that environmental factors initiate epidermal barrier dysfunction, thereby leading to AD development during infancy. To reveal the skin response-associated factors, we investigated the associations among skin responses to saline, histamine and purified protein derivative (PPD), AD, and environmental factors during infancy. METHODS: Total 256 infant-parent pairs were enrolled in this crosssectional study. We administered self-written questionnaires about family size, infants' daily yogurt intake, and physician-diagnosed AD. Skin prick tests (SPTs) to saline and histamine (1.0 mg/dl) were performed using bifurcated needles. SPT wheal sizes were recorded 15 minutes later. PPD responses were transcribed by the guardians using maternal and child health handbooks. RESULTS: Skin responses to histamine, not to saline and PPD, significantly differed between infants with and without AD (4.4 6 2.0 vs. 3.6 6 1.9 mm; P 5 0.04) and those with and without the yogurt intake (2.5 6 1.4 vs. 3.8 6 2.0 mm; P 5 0.01). Whereas, skin responses to PPD, not to histamine and saline, were significantly positively associated with family size (P 5 0.02), but not AD nor daily yogurt intake. CONCLUSIONS: During infancy, AD may be modified by the skin sensitivity to histamine and daily yogurt intakes, but not by T cells reacting to microbiomes. 
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